Molecular Imaging: Page 107

Copper radiotracers ID tumors, improve survival

By Rebekah Moan

Two copper radionuclides that target the somatostatin receptor overexpressed in neuroendocrine tumors can not only identify tumors but also improve survival, according to new research published in the December issue of the Journal of Nuclear Medicine.

December 20, 2020

FDA makes history with approval of Ga-68 PSMA-11 PET

By Wayne Forrest

The U.S. Food and Drug Administration's (FDA) recent approval of a PET radiotracer that targets lesions positive for prostate-specific membrane antigen (PSMA) is not only a "quantum leap" for the diagnosis of prostate cancer in men but also sets a precedent for academic research.

December 17, 2020

Shine breaks ground for new headquarters

By AuntMinnie.com staff writers

Shine Medical Technologies has broken ground in Janesville, WI, on a 54,000-sq-ft facility that will serve as its headquarters and a production facility for its new therapeutics division, established in 2019.

December 16, 2020

SNMMI: Imagers should get COVID-19 shots early

By AuntMinnie.com staff writers

Imaging professionals should be considered among the healthcare personnel prioritized for receiving COVID-19 vaccinations, according to the Society for Nuclear Medicine and Molecular Imaging (SNMMI).

December 16, 2020

TRIUMF inks deal for actinium-225 production

By AuntMinnie.com staff writers

Canadian particle accelerator center TRIUMF has entered a collaboration with Fusion Pharmaceuticals for the production of actinium-225, which has potential as a cancer-killing radioisotope.

December 15, 2020

AuntMinnie.com Molecular Imaging Insider

By Brian Casey

December 15, 2020

PET is useful modality in patients with lymphomas

By Louise Gagnon

PET imaging can permit more accurate staging in lymphomas, guide treatment, and make a difference in overall patient survival. That's the message from a discussion about imaging in patients with lymphomas at the virtual annual meeting of the American Society of Hematology in early December.

December 15, 2020

PET/MRI, CT predict pancreatic cancer treatment response

By Kate Madden Yee

Metabolic metrics tracked on PET/MRI and morphologic metrics tracked on CT show promise for evaluating tumor response to treatment and overall survival for patients with pancreatic ductal adenocarcinoma, according to a study published December 10 in the American Journal of Roetgenology.

December 13, 2020

SNMMI celebrates 60th anniversary with special issue

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is celebrating its 60th anniversary by issuing a special supplement of its Journal of Nuclear Medicine that features a collection of the most influential and frequently cited manuscripts in the JNM's history.

December 10, 2020

ACR launches new PET/Alzheimer's study

By AuntMinnie.com staff writers

The American College of Radiology (ACR) in collaboration with the Alzheimer's Association is launching a new research study that will show the value of brain PET scans for diagnosing Alzheimer's disease across a diverse patient population.

December 9, 2020

CMS grants pass-through status for Detectnet

By AuntMinnie.com staff writers

RadioMedix and Curium announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has granted transitional pass-through status to Detectnet PET diagnostic radiopharmaceutical copper-64 DOTATATE.

December 8, 2020

Point Biopharma to use Lantheus' PyL in clinical trial

By AuntMinnie.com staff writers

Point Biopharma will use Lantheus Medical Imaging's PyL radiopharmaceutical in its phase III clinical trial for patients with metastatic castration-resistant prostate cancer.

December 8, 2020

Previous Page

Page 107 of 614

Next Page